Letters Rosiglitazone saga Authors’ reply BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2573 (Published 21 April 2011) Cite this as: BMJ 2011;342:d2573 Article Related content Metrics Responses Peer review Related articles Letter Demonisation of rosiglitazone Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2571 Research Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies Published: 17 March 2011; BMJ 342 doi:10.1136/bmj.d1309 See more Sixty seconds on . . . 10 000 steps BMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598 Scarlett McNally: Enabling active travel can improve the UK’s health BMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522 Scarlett McNally: Boosting swimming for health and joy BMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393 Variability in blood pressure could help predict heart attack and stroke risk, researchers say BMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
